Vistin Pharma ASA : Invitation to presentation of Q1 2016 results

22 april 2016

Oslo, 22 April 2016

Vistin Pharma ASA (OSE: VISTIN), a producer of high quality API's and Solid Dosage Forms for the international pharmaceutical industry, will release its first quarter 2016 results on Thursday 28 April 2016.

The results will be presented by Vistin Pharma's CEO Kjell-Erik Nordby and CFO Gunnar Manum at 08:30 CET at Felix Konferansesenter, Bryggetorget 3, Oslo, Norway. Following the presentation, there will be a Q&A session. The presentation will be held in English.

The presentation will be webcast live and can be accessed directly from
http://webtv.hegnar.no/presentation.php?webcastId=33048918
or http://www.vistin.com/investors/webcast-article214-455.html .

The quarterly report and the presentation material will be available on www.vistin.com/investors and www.newsweb.no, as well as on news wires.

Vistin Pharma welcomes all interested parties.

For further information, please contact:

Gunnar Manum
CFO
+47 95 17 91 90
gunnar.manum@vistin.com

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Vistin Pharma ASA via GlobeNewswire

HUG#2005580